SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-042944
Filing Date
2024-05-14
Accepted
2024-05-14 16:12:50
Documents
15
Period of Report
2024-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0206088-8k_inmed.htm   iXBRL 8-K 28935
2 NEWS RELEASE, DATED MAY 14, 2024 ea020608801ex99-1_inmed.htm EX-99.1 105167
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-24-042944.txt   330932

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20240514.xsd EX-101.SCH 3021
4 XBRL LABEL FILE inm-20240514_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20240514_pre.xml EX-101.PRE 22364
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0206088-8k_inmed_htm.xml XML 3796
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 24944484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)